Company & Sponsor Intelligence
American University of Beirut Medical Center
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials3
Recruiting2
Completed0
Countries1
Therapeutic footprint
adhdalsother_psychiatry
Indexed studies
NCT03377309Safety and Tolerability of Perampanel in Amyotrophic Lateral Sclerosis Patients
als · LebanonPHASE2
als · LebanonPHASE2
NCT07686458Impact of the MIND Diet on ADHD Symptoms in Untreated Children
adhd · NA
adhd · NA
NCT07008950Self-efficacy and Knowledge (SEEK) Trial to Improve Sexual Reproductive Health and Well-being for Syrian Refugee Women and Girls in Lebanon
other_psychiatry · LebanonNA
other_psychiatry · LebanonNA
Intelligence layer updated: 2026-10-29 23:42:44.865458+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →